吗丁啉品牌怎么样 申请店铺

我要投票 吗丁啉在保健药品行业中的票数:730 更新时间:2025-08-30
吗丁啉是哪个国家的品牌?「吗丁啉」是 西安杨森制药有限公司 旗下著名品牌。该品牌发源于陕西,由创始人ASGAR DAVID RANGOONWALA在1985期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力吗丁啉品牌出海!将品牌入驻外推网,定制吗丁啉品牌推广信息,可以显著提高吗丁啉产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

吗丁啉怎么样


【吗丁啉®】用于消化不良、腹胀、嗳气、恶心、呕吐、腹部胀痛。口服。成人一次1片,一日3次,饭前15-30分钟服用。本品为胃肠促动力药非处方药药品。请仔细阅读说明书并按说明使用或在药师指导下购买和使用。

成立于1985年的西安杨森制药有限公司,是美国强生公司在华最大的子公司,也是中国最大的合资制药企业之一。生产基地位于西安,在全国28个城市设有办事处,在华员工超过3,000人。

公司业务包括生产和销售高质量的药品,产品主要涉及胃肠病学、神经精神学、变态反应学、疼痛管理学、抗感染、生物制剂和肿瘤等领域;除此之外,公司还致力于提供与健康相关的服务及开展大众健康教育。

西安杨森制药有限公司着眼于未来,不断引进新的药品,并努力提高中国的医疗卫生水平,以服务广大的中国患者。

西安杨森工厂位于历史悠久的古城西安,是中国西北地区最早建立的中外合资制药企业的工厂。它占地170亩,建筑面积35,620平米,绿化面积约占52%。主要建筑物包括制剂车间、动力运行、污水处理中心、行政办公楼、综合办公楼、员工餐厅等。

西安杨森工厂在生产及管理上均达到了中国和欧洲的药品生产质量管理规范(GMP)的标准,达到了国际标准化组织ISO9001:2000标准质量管理体系及ISO14001标准环境管理体系要求,达到了OHSAS职业安全健康管理体系的要求,这些有利于西安杨森与国外在提供产品与服务方面的交流。同时,西安杨森工厂还采用国际通行的现代企业管理制度,引进了SAP系统进行战略和运营管理,以世界级的生产设备、高科技的检测技术、严密的质量体系、卓越的国际物流系统,完成从原材料进厂、制造、包装到成品检验出厂的全过程,并对所有环节均进行严格地质量监控。稳固、高效的供应链系统,严谨、流畅的生产系统,高效、安全的国际化配送系统,以及严格、稹密的质量保证系统,已经使西安杨森工厂成为了全球的国际化的生产中心。这里生产的产品剂型有片剂、胶囊剂、乳膏剂、液剂、栓剂和散剂,包装类型有管装、瓶装、袋装和铝塑包装。

1997年,西安杨森工厂率先通过国家药品GMP认证。1999年,获得德国莱茵公司ISO9002质量管理体系认证。2003年完成ISO9001:2000升级认证。2004年10月和2007年9月,西安杨森工厂顺利通过了欧盟GMP审计署的首次审核和再次审核,标志着我们的厂房、设备、环境、人员、文件体系及质量管理体系完全符合欧洲GMP的标准,同时也保证了西安杨森在医药领域的先进性与国际化。

为了更好地服务于客户,西安杨森还在工厂建立了一个跨部门协作中心――客户关爱中心(CustomerCareCenter,简称CCC),设立24小时热线,随时倾听来自客户的声音,及时处理与反馈客户咨询及投诉。客户关爱中心人员具备医学、药学背景和专业知识的培训,在沟通互动中不仅传递专业信息,同时也将强生信条中“对客户负责”的理念以实际行动传递给了客户,从而赢得了客户赞誉,并赢得未来。

相关链接:【吗丁啉®】药品说明>>


[morpholine ®] is used for dyspepsia, abdominal distention, belching, nausea, vomiting, abdominal distention and pain. Oral administration. Adults take one tablet three times a day 15-30 minutes before meals. This is an over-the-counter drug for gastrointestinal motility. Please read the manual carefully and use it according to the instructions or purchase and use it under the guidance of pharmacist. Founded in 1985, Xi'an Janssen Pharmaceutical Co., Ltd. is the largest subsidiary of Johnson & Johnson in China and one of the largest pharmaceutical joint ventures in China. The production base is located in Xi'an, with offices in 28 cities and more than 3000 employees in China. The company's business includes the production and sale of high-quality drugs. Its products mainly involve Gastroenterology, neuropsychology, allergy, pain management, anti infection, biological agents and tumors. In addition, the company is committed to providing health-related services and developing public health education. Xi'an YANGSEN Pharmaceutical Co., Ltd. focuses on the future, constantly introduces new drugs, and strives to improve China's medical and health level to serve the vast number of Chinese patients. Located in the ancient city of Xi'an with a long history, Xi'an Janssen factory is the first Sino foreign joint venture pharmaceutical enterprise in Northwest China. It covers an area of 170 mu, with a building area of 35620 square meters and a greening area of about 52%. The main buildings include preparation workshop, power operation, sewage treatment center, administrative office building, comprehensive office building, staff restaurant, etc. In terms of production and management, Xi'an Janssen factory has reached the GMP standards of China and Europe, the ISO 9001:2000 standard quality management system and ISO14001 standard environmental management system, and the OHSAS occupational safety and health management system, which are conducive to the products and services provided by Xi'an Janssen and foreign countries Face to face communication. At the same time, Xi'an Janssen plant also adopts the internationally accepted modern enterprise management system and introduces SAP system for strategic and operational management. With world-class production equipment, high-tech testing technology, strict quality system and excellent international logistics system, it completes the whole process from raw material entering the plant, manufacturing, packaging to finished product inspection and leaving the factory, and strictly carries out all links Ground quality monitoring. A stable and efficient supply chain system, a rigorous and smooth production system, an efficient and safe international distribution system, and a strict and strict quality assurance system have made Xi'an YANGSEN factory a global international production center. The products produced here are tablets, capsules, creams, liquids, suppositories and powders. The packaging types include tube, bottle, bag and aluminum plastic packaging. In 1997, Xi'an Janssen factory took the lead in passing the national GMP certification. In 1999, it obtained the ISO9002 quality management system certification of German Rhine company. In 2003, ISO9001:2000 upgrade certification was completed. In October 2004 and September 2007, the Xi'an Yang Sen factory successfully passed the first audit and re examination of the GMP Audit Office of the European Union, marking that our factory buildings, equipment, environment, personnel, file system and quality management system fully comply with the European GMP standard, and also guaranteed the advanced nature and internationalization of Yang Sen in the field of medicine in Xi'an. In order to better serve customers, Xi'an Janssen has also established a cross department cooperation center customer care center (CCC) in the factory. It has set up a 24-hour hotline to listen to the voice from customers at any time, handle and feedback customer consultation and complaints in a timely manner. The staff of the customer care center have the training of medical and pharmaceutical background and professional knowledge. In the communication and interaction, they not only pass the professional information, but also pass the concept of "being responsible for customers" in Johnson's creed to the customers with practical actions, so as to win the praise of customers and win the future. Related links: [domperidone ®] Drug Description & gt; & gt;

本文链接: https://brand.waitui.com/5009730e4.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

贵州茅台:控股股东拟增持30亿元-33亿元

36氪获悉,贵州茅台发布公告,公司控股股东茅台集团计划自本次增持公告发布之日起6 个月内,通过集中竞价交易方式增持公司股票,拟增持金额不低于人民币30亿元(含)且不高于人民币33亿元(含)。

刚刚

阿里巴巴开发了一款新的AI芯片,目前正在测试中

36氪获悉,据报道,阿里巴巴开发了一款新的AI芯片,以填补英伟达在中国市场的空白。知情人士称,这款新芯片目前正在测试中,旨在服务于更广泛的人工智能推理任务,而且与英伟达兼容。新的芯片不再由台积电代工,转为由国内一家企业代工。

刚刚

蒋凡首次详解淘宝闪购战略:规模和心智目标超预期实现,长期效率将行业领先

8月29日,在2025年6月份季度财报分析师电话会上,阿里巴巴中国电商事业群CEO蒋凡首次详解淘宝闪购战略。他表示,淘宝闪购在订单规模、用户规模、商家供给和运力等方面均超出预期,外卖到家订单已行业领先,淘宝闪购在规模和心智上的阶段性目标已经超预期实现,长期将在效率上实现行业领先。他同时介绍,闪购显著带动淘宝电商业务,用户规模和活跃度持续增长,可以在长期保持价格竞争力的前提下,对平台整体产生明显正向经济收益。预计未来三年内随着百万品牌门店入驻,闪购和即时零售将为平台实现1万亿交易增量。

刚刚

美团闪购:七夕单量涨50%,鲜花销量破峰,数码、美妆等翻倍增长

8月29日,美团闪购发布数据显示:截至七夕当日晚10点,平台订单量较去年七夕同期增长50%,礼赠消费规模创新高。“闪购赠万物”成为七夕新风尚,呈现鲜明的多元化、品质化趋势,带动美团闪购鲜花销量破峰,数码电脑、美容护肤、珠宝首饰等销量翻倍增长。消费者在3C家电、美妆护肤等品类的平均消费金额较去年七夕大幅增长。受益于激增的礼赠需求,七夕当日,超500个美妆、3C、快消、百货品牌、零售商在美团闪购销量同比翻倍增长。

刚刚

鼎捷数智:上半年净利增6.09%,AI业务收入同比增长125.91%

8月29日,鼎捷数智发布2025年中期业绩报告。2025年上半年实现营业收入10.45亿元,同比增长4.08%;归母净利润4502.67万元,同比增长6.09%。上半年,公司发布四大工业软件AI智能套件,创新推出“Data+AI”技术理念,并构建“AI软基建”,AI业务收入同比增长125.91%。

刚刚

本页详细列出关于吗丁啉的品牌信息,含品牌所属公司介绍,吗丁啉所处行业的品牌地位及优势。
咨询